Please assess the completion status of the following clinical trial:

Trial Title: Behavior and Exercise Versus Drug Treatment in Men With Nocturia (BEDTiMe)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Nocturia ≥2 episodes / night average on the screening diary;~2. Willingness and appropriateness to receive an α- blocker;~3. Willingness to keep a bladder and sleep diary;~4. Willingness to wear a wrist actigraph; and~5. Willingness to make study visits~Exclusion Criteria:~1. Evidence of overt bladder outlet obstruction: peak uroflow \<4 mL/sec on a void of ≥125 mL, or a PVR of ≥ 300 mL;~2. Use of clean intermittent self-catheterization at home or having been instructed by a provider to do so within the last 12 months;~3. Genitourinary cancer, including active prostate cancer with ongoing surgical or radiation treatment, or the need of treatment, or bladder cancer, or persistent unexplained hematuria;~4. Obstructive sleep apnea with CPAP use, provider diagnosis with symptoms, or strong suspicion of diagnosis during screening;~5. Having Parkinson's disease with an uncontrolled tremor (invalidates wrist actigraphy);~6. Poorly controlled congestive heart failure as evidenced on physical examination;~7. Poorly controlled diabetes mellitus with either hemoglobin A1c of ≥ 7.5 or a random glucose ≥ 200 within last 3 months; or~8. Unstable health conditions expected to result in death or hospitalization within 3 months, as assessed by PI or Site PI;~9. Previously receiving intensive bladder training;~10. Allergic to Tamsulosin;~11. Previous spinal cord injury;~12. Currently on dialysis or in consideration for dialysis due to end stage renal disease;~13. More than 2 urinary tract infections within the last 12 months;~14. Not able to transfer independently from a wheelchair to the toilet;~15. Unstable dose of diuretic within the past 3 months;~16. Has an artificial urinary sphincter;~17. Impaired mental status;~18. TURP or other urologic surgery within the last 6 months.

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Behavioral and Exercise Therapy (M-BET) (Type: EXPERIMENTAL): Multicomponent behavior and exercise therapy program (M-BET) - pelvic floor muscle exercises, urge suppression strategies, fluid strategies, sleep hygiene \& non-pharmacological management of peripheral edema. M-BET alone will be given with placebo capsules.
- Drug Therapy w/ Behavioral Placebo (Type: ACTIVE_COMPARATOR): alpha-adrenergic antagonist medication with a placebo behavioral intervention
- Combination Therapy (Type: ACTIVE_COMPARATOR): Combination therapy: MBET and alpha-adrenergic antagonist medication

Based on this trial design, predict the completion outcome and termination type (if applicable).